Docetaxel (TaxotereTM) is active in non-small-cell lung cancer: a phase II trial of the EORTC early clinical trials group (ECTG)Thomas Cerny, S.B. Kaye, N. Pavlidis et al.|British Journal of Cancer|1994Cited by 161